These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 33866000)

  • 21. Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study.
    Omeish H; Najadat A; Al-Azzam S; Tarabin N; Abu Hameed A; Al-Gallab N; Abbas H; Rababah L; Rabadi M; Karasneh R; Aldeyab MA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1981086. PubMed ID: 34614383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study.
    Ali MD; Almadan LZ; Alghamdi RA; Alghamdi AS; Almarhoon SA; Hassan YAM; Ahmad A; Ghosn SA; Banu N; Eltrafi Z
    Infect Drug Resist; 2022; 15():4335-4346. PubMed ID: 35971558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers.
    Im JH; Kim E; Lee E; Seo Y; Lee Y; Jang Y; Yu S; Maeng Y; Park S; Park S; Kim J; Lee JS; Baek JH
    Yonsei Med J; 2021 Dec; 62(12):1162-1168. PubMed ID: 34816647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse Events following AstraZeneca COVID-19 Vaccine in Saudi Arabia: A Cross-Sectional Study among Healthcare and Nonhealthcare Workers.
    Alghamdi AA; Alkazemi A; Alissa A; Alghamdi I; Alwarafi G; Waggas HA
    Intervirology; 2022; 65(2):104-109. PubMed ID: 34544075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan.
    Mori M; Yokoyama A; Shichida A; Sasuga K; Maekawa T; Moriyama T
    Microbiol Spectr; 2022 Dec; 10(6):e0130922. PubMed ID: 36314943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey.
    Baydar O; Özen Ş; Öztürk Şahin B; Köktürk N; Kitapçı MT
    Balkan Med J; 2022 May; 39(3):193-198. PubMed ID: 35380034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare Staff Perceptions Following Inoculation with the BNT162b2 mRNA COVID-19 Vaccine at University Hospitals Coventry & Warwickshire NHS Trust.
    Robbins T; Kyrou I; Clark C; Sharma K; Laird S; Berry L; Morgan N; Patel K; Sankar S; Randeva H
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501970
    [No Abstract]   [Full Text] [Related]  

  • 28. High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data.
    Hashimoto T; Ozaki A; Bhandari D; Sawano T; Sah R; Tanimoto T
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34128049
    [No Abstract]   [Full Text] [Related]  

  • 29. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
    Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Hatmal M; Alhaj-Qasem DM; Olaimat TM; Mohamud R
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects.
    Quiroga B; Sánchez-Álvarez E; Goicoechea M; de Sequera P;
    J Healthc Qual Res; 2021; 36(6):363-369. PubMed ID: 34244126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals.
    Tsatsakis A; Vakonaki E; Tzatzarakis M; Flamourakis M; Nikolouzakis TK; Poulas K; Papazoglou G; Hatzidaki E; Papanikolaou NC; Drakoulis N; Iliaki E; Goulielmos GN; Kallionakis M; Lazopoulos G; Kteniadakis S; Alegkakis A; Farsalinos K; Spandidos DA
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34515322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
    Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Feb; 174(2):JC15. PubMed ID: 33524290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.
    Bianchi FP; Germinario CA; Migliore G; Vimercati L; Martinelli A; Lobifaro A; Tafuri S; Stefanizzi P;
    J Infect Dis; 2021 Aug; 224(3):431-434. PubMed ID: 34007998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta's state hospital.
    Cuschieri S; Borg M; Agius S; Souness J; Brincat A; Grech V
    Int J Clin Pract; 2021 Oct; 75(10):e14605. PubMed ID: 34228863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers.
    Otani J; Ohta R; Sano C
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-vaccination (COVID-19) impacts in healthcare personnel.
    Shahid S; Ghayyur A; Majeed A; Nisar S; Chaudary MA
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1957-1962. PubMed ID: 34836866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
    Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
    Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.